|
Herb-Drug Interactions for Cancer
July Footnotes
By Narda G. Robinson, DO, DVM, MS, FAAMA
1. The Associated Press. “Judge rules family can’t refuse chemo for boy.” Updated May 19, 2009. Accessed at www.msnbc.msn.com/id/30763438/ on May 22, 2009.
2. The Associated Press. “Teen cancer patient, mom on the run.” Posted May 21, 2009. Accessed at news.aol.ca/article/teen-cancer-patient-mom-on-the-run/628206/ on May 23, 2009.
3. Hwang S-W, Han H-S, and Lim KY. “Drug interaction between complementary herbal medicines and gefitinib.” Journal of Thoracic Oncology. 2008;3(8):942.
4. Engdal S, Klepp O, and Nilsen OG. “Identification and exploration of herb-drug combinations used by cancer patients.” Integrative Cancer Therapies. 2009;8(1):29-36.
5-6. Michaud LB, Karpinski JP, Jones KL, et al. “Dietary supplements in patients with cancer: Risks and key concepts, Part 1.” Am J Health-Syst Pharm. 2007;64:369-381.
7. Bairati I, Meyer F, Jobin E, et al. “Antioxidant vitamins supplementation and mortality: A randomized trial in head and neck cancer patients.” Int J Cancer. 2006;119:2221-2224.
8. Meyer F, Bairati I, Jobin E, et al. “Acute adverse effects of radiation therapy and local recurrence in relation to dietary and plasma beta carotene and alpha tocopherol in head and neck cancer patients.” Nutrition and Cancer. 2007;59(1):29-35.
9-11. Michaud LB, Karpinski JP, Jones KL, et al. “Dietary supplements in patients with cancer: Risks and key concepts, Part 1.” Am J Health-Syst Pharm. 2007;64:369-381.
12-13. Hardy ML. “Dietary supplement use in cancer care: Help or harm.” Hematol Oncol Clin North Am. 2008;22(4):581-617, vii. Review.
14. Griessmayr PC, Gautheir M, Barber LG, et al. “Mushroom-derived maitake PETfraction as a single agent for the treatment of lymphoma in dogs.” Journal of Veterinary Internal Medicine. 2007;21(6):1409-1412.
15-16. Hardy ML. “Dietary supplement use in cancer care: Help or harm.” Hematol Oncol Clin North Am. 2008;22(4):581-617, vii. Review.
17. Biondo PD, Brindley DN, Sawyer MB, et al. “The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy.” Journal of Nutritional Biochemistry. 2008;19:787-796.
18. Selting KA, Ogilvie GK, Gustafson DL, et al. “Evaluation of the effects of dietary n-3 fatty acid supplementation on the pharmacokinetics of doxorubicin in dogs with lymphoma.” American Journal of Veterinary Research. 2006;67(1):145-151.
Give us your opinion on Herb-Drug Interactions for Cancer
Industry Professional Site: Comments from non-industry professionals will be removed.
|